Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 1
1963 2
1964 3
1965 2
1967 4
1968 7
1969 2
1970 1
1971 1
1973 2
1979 2
1980 2
1981 2
1982 1
1983 1
1985 2
1991 1
2008 1
2009 2
2010 1
2011 1
2014 2
2019 4
2020 6
2021 5
2022 8
2023 10
2024 15
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study.
Giacobbe DR, Labate L, Russo Artimagnella C, Marelli C, Signori A, Di Pilato V, Aldieri C, Bandera A, Briano F, Cacopardo B, Calabresi A, Capra Marzani F, Carretta A, Cattelan A, Ceccarelli L, Cenderello G, Corcione S, Cortegiani A, Cultrera R, De Rosa FG, Del Bono V, Del Puente F, Fanelli C, Fava F, Francisci D, Geremia N, Graziani L, Lombardi A, Losito AR, Maida I, Marino A, Mazzitelli M, Merli M, Monardo R, Mularoni A, Oltolini C, Pallotto C, Pontali E, Raffaelli F, Rinaldi M, Ripa M, Santantonio TA, Serino FS, Spinicci M, Torti C, Trecarichi EM, Tumbarello M, Mikulska M, Giacomini M, Marchese A, Vena A, Bassetti M; CEFI-SITA investigators. Giacobbe DR, et al. Infect Dis Ther. 2024 Sep;13(9):1929-1948. doi: 10.1007/s40121-024-01016-y. Epub 2024 Jul 12. Infect Dis Ther. 2024. PMID: 38995601 Free PMC article.
In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry.
Esposito S, Pagliano P, De Simone G, Guarino A, Pan A, Brambilla P, Mastroianni C, Lichtner M, Brugnaro P, Carretta A, Santantonio T, Brindicci G, Carrega G, Montagnani F, Lapadula G, Spolti A, Luzzati R, Schiaroli E, Scaglione V, Pallotto C, Tacconi D, Quintieri F, Trecarichi E; Italian Society of Infectious, Tropical Diseases. Esposito S, et al. Among authors: scaglione v. Infection. 2024 Aug;52(4):1297-1306. doi: 10.1007/s15010-024-02176-2. Epub 2024 Feb 7. Infection. 2024. PMID: 38324144 Free PMC article.
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study.
Vena A, Schenone M, Corcione S, Giannella M, Pascale R, Giacobbe DR, Muccio M, Mornese Pinna S, Pari B, Giovannenze F, Geremia N, Mikulska M, Taddei E, Sangiorgi F, Bavaro DF, Scaglione V, Vassia V, Merli M, Bartoletti M, Viale P, De Rosa FG, Bassetti M. Vena A, et al. Among authors: scaglione v. J Antimicrob Chemother. 2024 Nov 4;79(11):2846-2853. doi: 10.1093/jac/dkae296. J Antimicrob Chemother. 2024. PMID: 39224938
Assessing ChatGPT's theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists.
De Vito A, Geremia N, Marino A, Bavaro DF, Caruana G, Meschiari M, Colpani A, Mazzitelli M, Scaglione V, Venanzi Rullo E, Fiore V, Fois M, Campanella E, Pistarà E, Faltoni M, Nunnari G, Cattelan A, Mussini C, Bartoletti M, Vaira LA, Madeddu G. De Vito A, et al. Among authors: scaglione v. Infection. 2024 Jul 12. doi: 10.1007/s15010-024-02350-6. Online ahead of print. Infection. 2024. PMID: 38995551
Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses.
Mazzitelli M, Scaglione V, Cattarin L, Franchin E, Stano P, Paci L, Coppi M, Rossolini GM, Mengato D, Calò L, Cattelan AM. Mazzitelli M, et al. Among authors: scaglione v. J Antimicrob Chemother. 2024 Mar 1;79(3):689-691. doi: 10.1093/jac/dkad410. J Antimicrob Chemother. 2024. PMID: 38225167 No abstract available.
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19?
Serapide F, Quirino A, Scaglione V, Morrone HL, Longhini F, Bruni A, Garofalo E, Matera G, Marascio N, Scarlata GGM, Cicino C, Russo A, Trecarichi EM, Torti C. Serapide F, et al. Among authors: scaglione v. Microorganisms. 2022 May 2;10(5):957. doi: 10.3390/microorganisms10050957. Microorganisms. 2022. PMID: 35630400 Free PMC article.
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital.
Scaglione V, Reale M, Davoli C, Mazzitelli M, Serapide F, Lionello R, La Gamba V, Fusco P, Bruni A, Procopio D, Garofalo E, Longhini F, Marascio N, Peronace C, Giancotti A, Gallo L, Matera G, Liberto MC, Cesana BM, Costa C, Trecarichi EM, Quirino A, Torti C. Scaglione V, et al. Microb Drug Resist. 2022 Apr;28(4):425-435. doi: 10.1089/mdr.2021.0109. Epub 2021 Dec 15. Microb Drug Resist. 2022. PMID: 34910885 Free PMC article.
90 results